See more : Wuhan Citms Technology CO.,LTD. (688038.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Berkeley Lights, Inc. (BLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Berkeley Lights, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- ALTEOGEN Inc. (196170.KQ) Income Statement Analysis – Financial Results
- Fire & Flower Holdings Corp. (FAF.TO) Income Statement Analysis – Financial Results
- Next Mediaworks Limited (NEXTMEDIA.NS) Income Statement Analysis – Financial Results
- SKC Co., Ltd. (011790.KS) Income Statement Analysis – Financial Results
- Mobilum Technologies Inc. (MBLM.CN) Income Statement Analysis – Financial Results
Berkeley Lights, Inc. (BLI)
About Berkeley Lights, Inc.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 78.60M | 85.39M | 64.30M | 56.69M | 31.30M |
| Cost of Revenue | 24.81M | 28.84M | 19.75M | 13.22M | 8.18M |
| Gross Profit | 53.78M | 56.55M | 44.56M | 43.48M | 23.12M |
| Gross Profit Ratio | 68.43% | 66.23% | 69.29% | 76.69% | 73.86% |
| Research & Development | 53.21M | 58.55M | 47.24M | 38.41M | 29.08M |
| General & Administrative | 0.00 | 43.40M | 23.20M | 12.36M | 9.07M |
| Selling & Marketing | 0.00 | 25.39M | 14.51M | 9.24M | 6.13M |
| SG&A | 95.12M | 68.79M | 37.71M | 21.60M | 15.20M |
| Other Expenses | -246.00K | 6.00K | 82.00K | -1.18M | 0.00 |
| Operating Expenses | 148.32M | 127.34M | 84.95M | 60.01M | 44.28M |
| Cost & Expenses | 173.14M | 156.18M | 104.70M | 73.23M | 52.46M |
| Interest Income | 1.27M | 175.00K | 338.00K | 909.00K | 872.00K |
| Interest Expense | 910.00K | 1.17M | 1.44M | 1.43M | 2.20M |
| Depreciation & Amortization | 1.02M | 181.00K | 420.00K | 6.24M | 4.29M |
| EBITDA | -93.52M | -70.61M | -39.97M | -10.29M | -16.87M |
| EBITDA Ratio | -118.99% | -82.69% | -62.17% | -18.16% | -53.89% |
| Operating Income | -94.54M | -70.79M | -40.39M | -16.54M | -21.16M |
| Operating Income Ratio | -120.29% | -82.90% | -62.82% | -29.17% | -67.60% |
| Total Other Income/Expenses | -3.40M | -990.00K | -1.02M | -1.70M | -2.11M |
| Income Before Tax | -97.94M | -71.78M | -41.41M | -18.23M | -23.27M |
| Income Before Tax Ratio | -124.61% | -84.06% | -64.40% | -32.16% | -74.34% |
| Income Tax Expense | 100.00K | -55.00K | 174.00K | 69.00K | 69.00K |
| Net Income | -98.04M | -71.72M | -41.58M | -18.30M | -23.34M |
| Net Income Ratio | -124.74% | -84.00% | -64.67% | -32.28% | -74.56% |
| EPS | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
| EPS Diluted | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
| Weighted Avg Shares Out | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
| Weighted Avg Shares Out (Dil) | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022
EMERYVILLE, Calif. , July 21, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the second quarter 2022 after market on Tuesday, August 9, 2022.
Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting
Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform
Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities
EMERYVILLE, Calif. & ALBANY, N.Y.--(BUSINESS WIRE)--Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s adoption of The Beacon® Optofluidic system and workflows...
Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities
EMERYVILLE, Calif. & ALBANY, N.Y.--(BUSINESS WIRE)-- #AMRI--Curia now provides a comprehensive portfolio of state-of-the-art technologies and experience for rapid progression of client antibody programs.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Berkeley Lights, Inc.
Wilmington, Delaware--(Newsfile Corp. - May 31, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Berkeley Lights, Inc. (NASDAQ: BLI) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-berkeley-lights-inc.To...
Berkeley Lights, Inc. (BLI) CEO Siddhartha Kadia on Q1 2022 Results - Earnings Call Transcript
Berkeley Lights, Inc. (NASDAQ:BLI ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Suzanne Hatcher - Vice President, Communications & Investor Relations Siddhartha Kadia - Chief Executive Officer Paul McClaskey - Chief Accounting Officer Eric...
Berkeley Lights, Inc. (BLI) Reports Q1 Loss, Lags Revenue Estimates
Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -3.23% and 1.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Berkeley Lights Reports First Quarter 2022 Financial Results
EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended March 31, 2022.
Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo
Company's latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification” Company's latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification”
BERKELEY LIGHTS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Berkeley Lights, Inc. - BLI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Berkeley Lights, Inc. (NasdaqGS: BLI). On September...
Source: https://incomestatements.info
Category: Stock Reports